A28.2 Extraintestinal yersiniosis

✓ Billable ICD-10-CM 2026
Open A28.2 in Web App →

The ICD-10-CM code for Extraintestinal yersiniosis is A28.2 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
A20-A28: Certain zoonotic bacterial diseases (A20-A28)
Category A28
6 codes (5 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to A28.2:

  • Pseudotuberculosis
  • Yersiniosis › extraintestinal
  • Sepsis (generalized) (unspecified organism) › extraintestinal yersiniosis
  • Infection, infected, infective (opportunistic) › Yersinia › pseudotuberculosis
Excludes1
Not coded here. These conditions should NOT be coded together with A28.2.
  • enteritis due to Yersinia enterocolitica (A04.6)
  • plague (A20.-)

U.S. Hospital Utilization

A28.2 appeared in too few sampled U.S. inpatient stays in 2023 to report a national estimate (AHRQ suppresses counts of 10 or fewer) — a rare inpatient diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

HIV Infections (TOC entry)

a. Human Immunodeficiency Virus (HIV) Infections .............................................................. 19

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.1.a
Infectious agents causing diseases in other chapters (TOC)

b. Infectious agents as the cause of diseases classified to other chapters ................................. 22

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.1.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial